The newly approved PrecivityAD2 test offers an easier, less invasive way to identify Alzheimer’s disease in patients.
Live Poll
Do you trust that new medical diagnostic tests are sufficiently validated for all racial groups?
September 24, 2026
AI Tool Developed for Alzheimer’s Target DiscoveryResearchers created an autonomous system to identify potential treatment targets for Alzheimer’s disease.
September 24, 2026
APOE4 Gene Mechanism Linked to Alzheimer’s Brain DamageResearchers identified how this genetic risk factor damages brain blood vessels and impairs waste disposal in cells.
September 24, 2026
Brain-Computer Interface Developer Raised $250 MillionThe funding supports new technology designed to record brain activity with less invasive procedures.
September 23, 2026
Debbie Allen, Merck Launched HIV Support ProgramThe Your Hive of Whole Health initiative offers resources to help people with HIV build personalized support networks.
September 23, 2026
Brain Cell Discovery Linked to Epilepsy TreatmentResearchers identified a specific astrocyte reaction in tuberous sclerosis that may inform future epilepsy therapies.
September 23, 2026
Depression Linked to Reduced Brain Cell GrowthResearchers found distinct cellular activity in the hippocampus of adults with depression.
September 23, 2026
Paliperidone Study Proposed New Dosing SchedulesResearchers modeled whether higher doses of a schizophrenia medication could safely extend the time between treatments.
September 23, 2026
Chesley Sullenberger Announced Alzheimer’s DiagnosisThe former pilot is advocating for early testing after receiving his own diagnosis last year.
September 23, 2026
Research Grant Program Expanded to Include Sleep DisordersEarly-career investigators studying narcolepsy and hypersomnia can now apply for funding support.
September 23, 2026
AI Tools Have Improved Detection of Alzheimer’s Therapy Side EffectsA new medical panel suggests that artificial intelligence can better identify ARIA in patients using anti-amyloid treatments.
